elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33793476-83C860C2-14A1-4123-9A43-5785E7045B43
Q33793476-83C860C2-14A1-4123-9A43-5785E7045B43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33793476-83C860C2-14A1-4123-9A43-5785E7045B43
B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis.
P2860
Q33793476-83C860C2-14A1-4123-9A43-5785E7045B43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33793476-83C860C2-14A1-4123-9A43-5785E7045B43
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
142c5d3997c2b0f98835b78e37e7606764e3c260
P2860
What is new in the management of rapidly progressive glomerulonephritis?